108 related articles for article (PubMed ID: 22586047)
1. Extended use of serum free light chain as a biomarker in lymphoproliferative disorders: a comprehensive review.
Charafeddine KM; Jabbour MN; Kadi RH; Daher RT
Am J Clin Pathol; 2012 Jun; 137(6):890-7. PubMed ID: 22586047
[TBL] [Abstract][Full Text] [Related]
2. Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Martin W; Abraham R; Shanafelt T; Clark RJ; Bone N; Geyer SM; Katzmann JA; Bradwell A; Kay NE; Witzig TE
Transl Res; 2007 Apr; 149(4):231-5. PubMed ID: 17383597
[TBL] [Abstract][Full Text] [Related]
3. Free light chain: a novel predictor of adverse outcome in chronic lymphocytic leukemia.
Yegin ZA; Ozkurt ZN; Yağci M
Eur J Haematol; 2010 May; 84(5):406-11. PubMed ID: 20059535
[TBL] [Abstract][Full Text] [Related]
4. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
[TBL] [Abstract][Full Text] [Related]
5. Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia.
Pratt G; Harding S; Holder R; Fegan C; Pepper C; Oscier D; Gardiner A; Bradwell AR; Mead G
Br J Haematol; 2009 Jan; 144(2):217-22. PubMed ID: 19016722
[TBL] [Abstract][Full Text] [Related]
6. Serum free light chain (FLC) measurement can aid capillary zone electrophoresis in detecting subtle FLC-producing M proteins.
Bakshi NA; Gulbranson R; Garstka D; Bradwell AR; Keren DF
Am J Clin Pathol; 2005 Aug; 124(2):214-8. PubMed ID: 16040291
[TBL] [Abstract][Full Text] [Related]
7. The prognostic utility and the association of serum light chains (free and total) and absolute lymphocyte count in patients with newly diagnosed diffuse large B-cell lymphoma.
Han X; Wang J; Zhang N; Yao J; Feng Y; Li D; Liu P; Yang J; Zhou S; Qin Y; Yang S; Gui L; He X; Shi Y
Leuk Res; 2014 Nov; 38(11):1291-8. PubMed ID: 25287608
[TBL] [Abstract][Full Text] [Related]
8. Abnormal serum free light chain ratio predicts poor overall survival in mantle cell lymphoma.
Furtado M; Shah N; Levoguer A; Harding S; Rule S
Br J Haematol; 2013 Jan; 160(1):63-9. PubMed ID: 23094783
[TBL] [Abstract][Full Text] [Related]
9. Serum free light chain assay reduces the need for serum and urine immunofixation electrophoresis in the evaluation of monoclonal gammopathy.
Fulton RB; Fernando SL
Ann Clin Biochem; 2009 Sep; 46(Pt 5):407-12. PubMed ID: 19641008
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
Kyrtsonis MC; Vassilakopoulos TP; Kafasi N; Sachanas S; Tzenou T; Papadogiannis A; Galanis Z; Kalpadakis C; Dimou M; Kyriakou E; Angelopoulou MK; Dimopoulou MN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Panayiotidis P; Pangalis GA
Br J Haematol; 2007 May; 137(3):240-3. PubMed ID: 17408464
[TBL] [Abstract][Full Text] [Related]
11. Replacing urine protein electrophoresis with serum free light chain analysis as a first-line test for detecting plasma cell disorders offers increased diagnostic accuracy and potential health benefit to patients.
McTaggart MP; Lindsay J; Kearney EM
Am J Clin Pathol; 2013 Dec; 140(6):890-7. PubMed ID: 24225758
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
13. [Determination of light chains in serum].
Hansen CT; Nielsen L; Münster AM; Abildgaard N
Ugeskr Laeger; 2010 Aug; 172(34):2302-5. PubMed ID: 20727297
[TBL] [Abstract][Full Text] [Related]
14. [The roles of serum free light chain ratio in the diagnosis and prognosis of newly diagnosed multiple myeloma].
Wang PF; Xu Y; Yan S; Yao Y; Zheng HF; Ma L; Jin S; Xu Y; Gong FR; Zhou JZ; Chang HR; Fu CC
Zhonghua Xue Ye Xue Za Zhi; 2016 May; 37(5):377-82. PubMed ID: 27210871
[TBL] [Abstract][Full Text] [Related]
15. Serum immunoglobulin free light chain and heavy/light chain measurements in POEMS syndrome.
Wang C; Su W; Zhang W; Di Q; Duan MH; Ji W; Cao XX; Zhou DB; Li J
Ann Hematol; 2014 Jul; 93(7):1201-6. PubMed ID: 24482101
[TBL] [Abstract][Full Text] [Related]
16. The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia.
Morabito F; De Filippi R; Laurenti L; Zirlik K; Recchia AG; Gentile M; Morelli E; Vigna E; Gigliotti V; Calemma R; Amoroso B; Neri A; Cutrona G; Ferrarini M; Molica S; Del Poeta G; Tripodo C; Pinto A
Blood; 2011 Dec; 118(24):6353-61. PubMed ID: 21998207
[TBL] [Abstract][Full Text] [Related]
17. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
[TBL] [Abstract][Full Text] [Related]
18. [Detection of serum free light chain and its clinical significance in nonsecretory multiple myeloma].
Chen HF; Hou J; Yuan ZG; Wang DX; Fu WJ; Chen YB
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):113-6. PubMed ID: 18681313
[TBL] [Abstract][Full Text] [Related]
19. The evolving use of serum free light chain assays in haematology.
Pratt G
Br J Haematol; 2008 May; 141(4):413-22. PubMed ID: 18318757
[TBL] [Abstract][Full Text] [Related]
20. [Kidney failure in a patient with chronic B-lymphocytic leukaemia (B-CLL) with underlying cast nephropathy. The value of free immunoglobulin light chain identification for early diagnosis of this complication].
Adam Z; Stepánková S; Sirotková A; Cermáková Z; Pour L; Krejcí M; Zahradová L; Korístek Z; Lenz J; Hájek R; Vorlícek J; Mayer J
Vnitr Lek; 2011 Feb; 57(2):214-21. PubMed ID: 21416862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]